P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT
FEDERICI C.,
KUCUKAL E.,
KOCEVAR R.,
GILKEY L.,
SERTEL S.,
MONCHAMP K.,
WOLFE A.,
NAYAK L.,
BRUEDERLE A.,
ZAK J.,
GURKAN U.
Affiliations
FEDERICI C.
1 Biochip Labs, Cleveland, UNITED STATES
KUCUKAL E.
1 Biochip Labs, Cleveland, UNITED STATES
KOCEVAR R.
1 Biochip Labs, Cleveland, UNITED STATES
GILKEY L.
1 Biochip Labs, Cleveland, UNITED STATES
SERTEL S.
1 Biochip Labs, Cleveland, UNITED STATES
MONCHAMP K.
3 Department of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, UNITED STATES
WOLFE A.
3 Department of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, UNITED STATES
NAYAK L.
1 Biochip Labs, Cleveland, UNITED STATES
BRUEDERLE A.
6 Novartis Pharma AG, Global Drug Development, Basel, SWITZERLAND
